Learning outcomes – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

Master of Industrial Drug Development > For students > Learning outcomes

Learning outcomes

The Master of Industrial Drug Development (MIND) programme equips graduates with the following knowledge, skills and competences:

Knowledge

MIND graduates have demonstrated knowledge and understanding of the following subjects:

  • target identification and validation methods and processes
  • lead optimisation methods and processes
  • principal steps and methodologies in drug discovery and development including translational steps
  • principal steps in discovering, modifying, assessing, producing and patenting new chemical and biological compounds
  • the overall development plan involving medicinal chemical, pharmaceutical, non-clinical and clinical development
  • quality assurance
  • regulation of medicines in the EU
  • management of drug safety issues before and after market authorisation
  • management of lifecycle activities (regulatory and marketing) of a medicine
  • ethical and legal provisions in drug development

MIND graduates have in-depth knowledge based on the highest level of international research in one or more subject areas in a selected field.  On this scientific basis, graduates are equipped to understand and reflect on the knowledge of the other subject areas and identify scientific issues.

Skills

MIND graduates are able to:

  • apply basic computational methods in the areas of bioinformatics and structure-based drug design
  • adhere to GMP and GCP guidelines for drug products
  • apply knowledge of drug regulatory affairs to work tasks and project strategies
  • schedule and integrate non-clinical tests into overall drug development and assess their predictive value
  • perform early studies in patients: dose-finding and proof-of-concept studies
  • design a confirmatory clinical development plan
  • perform a benefit/risk assessment throughout the lifecycle management of a medicine

Competencies

MIND graduates are able to:

  • effectively and critically evaluate each stage of the drug development process and predict future bottlenecks
  • critically evaluate validation  of drug targets
  • manage and develop complex work situations related to drug discovery and development
  • critically evaluate chemical process development projects
  • independently initiate and carry out discipline-specific and interdisciplinary collaboration related to drug development
  • initiate, plan, implement and assume professional responsibility for drug development projects from discovery to clinical trials and registration
  • organise the elements of a drug development programme
  • liaise and communicate professionally, using scientific terminology, with other specialist groups within the drug development industry
  • take independent responsibility for own professional development.